Altimmune, Inc. (ALT) vs CorMedix Inc (CRMD)
Altimmune, Inc. and CorMedix Inc are both Biotechnology companies. Altimmune, Inc. and CorMedix Inc are of similar size ($608.0M and $593.3M). Altimmune, Inc. has negative trailing earnings, so its P/E is not meaningful; CorMedix Inc trades at 3.3×. CorMedix Inc grew revenue faster over the last twelve months: 280.5% against 130.0%. CorMedix Inc has the higher net margin (40.5% vs 0.00%) and the higher return on invested capital (38.8% vs −34.3%). Across the 18 metrics below, CorMedix Inc leads on 14 and Altimmune, Inc. on 4.
Valuation
Profitability
| Metric | ALT | CRMD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 82.78% | 65.16% |
| Operating margin | 0.00% | 46.95% | 0.00% |
| Net margin | 0.00% | 40.49% | 0.00% |
| Free cash flow margin | 0.00% | 54.17% | 0.00% |
| Return on equity | (28.87%) | 54.93% | (57.72%) |
| Return on assets | (25.58%) | 32.36% | (49.22%) |
| Return on invested capital | (34.30%) | 38.84% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack